Latest return on equity
MoonLake Immunotherapeutics Return on equity
Direct answer
MoonLake Immunotherapeutics's return on equity is -67.47%.
The verified market snapshot reports -67.47%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -67.47%
Explore related company data
View MoonLake Immunotherapeutics's market capitalizationView MoonLake Immunotherapeutics's price-to-book ratioView MoonLake Immunotherapeutics's dividend yieldView MoonLake Immunotherapeutics's 52-week price rangeView MoonLake Immunotherapeutics's profit marginView MoonLake Immunotherapeutics's debt-to-equity ratioView all MoonLake Immunotherapeutics key metricsReturn to MoonLake Immunotherapeutics profile